Open access
Aug 2026
Plasma GFAP modifies the association of depressive symptoms with cognitive function: A population‐based study
Late‐life depression is associated with cognitive impairment, but the underlying neural basis remains to be elucidated. We investigated the role of Alzheimer's disease (AD)–related plasma biomarkers in the depression–cognition association.
Shuai Chen, Fengyu Wang, Yu-Xiang Jiao et al.
· Alzheimer's & Dementia · 0 citations